Bell Wire

Avecho Biotechnology Limited Phase III Insomnia Trial Clears Interim Analysis, No Sample Size Increase Required Avecho Biotechnology Limited (ASX: AVE) has received unanimous recommendation from an independent Data Monitoring Board to continue its pivotal Phase III insomnia trial to full enrolment of 519 participants, with no increase in sample size required… Read more: https://buff.ly/e0ccbZE Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #AVE #Biotech #Health #ASX #Markets

N1 Holdings | Private Credit Posts $1.2M Pre-Tax Profit as Private Credit Settlements Hit Record Amount: $1.21M pre-tax profit (unaudited) for FY26; $1.50M EBITDA (unaudited) Revenue: $21.67M for FY26, up 10.0% year-on-year Cash receipts: $7.57M for Q4 FY26, up 28% on prior corresponding period Operating cash flow: $14.32M net… Read more: https://buff.ly/esy6Bfn Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #N1H #Markets #Finance #ASX

Health Care leads the charge as CPI surprise lifts all boats, tech rides the risk-on wave A softer-than-expected Australian CPI print killed off August rate-rise bets and sent the ASX 200 up 1.02% at close on 29 July. Health Care was the standout sector, surging 4.24%, while the ASX All Technology Index added 1.08%. Biotech dominated the day's individual movers. Read more: https://buff.ly/ieZkdE1 Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #ASX #Markets

Invictus Therapeutics Secures US Patent for Tocotrienol Delivery Method Invictus Therapeutics (NSX: VTL) has received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering an improved manufacturing method for transmucosal tocotrienol formulations, extending the company's… Read more: https://buff.ly/WWiBqml Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #VTL #Biotech #Health #ASX #Markets

Odyssey Gold Scoping Study Points to A$180M Pre-Tax Cash at Tuckanarra Odyssey Gold (ASX: ODY) has completed a Stage 1 scoping study for its Tuckanarra gold project in Western Australia's Murchison region, projecting approximately 79,000 ounces of recovered gold over 29 months and net pre-tax cashflows of A$180… Read more: https://lnkd.in/g7x683CW Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #ODY #Gold #PreciousMetals #ASX #Markets

ASF Group Lifts Cash to $5.2M After $3.5M Asset Sales ASF Group Limited (ASX: AFA) closed the June quarter with $5.19 million in cash after completing $3.55 million in non-core asset disposals, quadrupling its cash position from $1.56 million at the start of the quarter and extending its funding runway… Read more: https://lnkd.in/g-7an7Px Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #AFA #Markets #Finance #ASX

FMR Resources Hits 124m at 0.31% CuEq at Llahuin as Phase I Drilling Wraps FMR Resources (ASX: FMR) has completed its maiden diamond drilling campaign at the Southern Porphyry target within the Llahuin joint venture in central Chile, returning broad intercepts of gold-molybdenum-copper mineralisation that the company… Read more: https://lnkd.in/ga2M8agV Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #FMR #BaseMetals #ASX #Markets

Orpheus Uranium Commences 35-Hole Drill Program at Frome Project Orpheus Uranium (ASX: ORP) has commenced drilling at its Frome Project in South Australia, with a rig now on site at the Erudina prospect to test a 12-kilometre interpreted uranium-bearing palaeochannel system. Read more: https://lnkd.in/gfmgzufs Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #ORP #Energy #ASX #Markets

Nickel Industries Limited Posts US$256m First-Half EBITDA as Hengjaya Mine Hits Record Quarter Nickel Industries Limited (ASX: NIC) delivered unaudited first-half 2026 EBITDA from operations of US$256 million, approaching the full-year 2025 result of US$283 million in just six months. Read more: https://lnkd.in/gYfPFF9y Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #NIC #BaseMetals #ASX #Markets

ReNerve Limited Posts Record $211k Quarter as Cash Runway Falls Below One Quarter ReNerve Limited (ASX: RNV) delivered its strongest sales quarter to date with $211,000 in revenue for Q4 FY26, up more than 50% on the prior quarter, but closed the period with just 0.9 quarters of cash runway before drawing on a newly secured… Read more: https://lnkd.in/g3KjDFv8 Every announcement, minutes after it lands. Like this post and follow Bell Wire to keep the record coming. #RNV #Biotech #Health #ASX #Markets